We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
RESEARCH SUPPORT, NON-U.S. GOV'T
Elevated Dopamine D 2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [ 11 C](+)PHNO.
Neuropsychopharmacology 2016 December
Most prior work with positron emission tomography (PET) dopamine subtype 2/3 receptor (D2/3 R) non-selective antagonist tracers suggests that obese (OB) individuals exhibit lower D2/3 Rs when compared with normal weight (NW) individuals. A D3 -preferring D2/3 R agonist tracer, [11 C](+)PHNO, has demonstrated that body mass index (BMI) was positively associated with D2/3 R availability within striatal reward regions. To date, OB individuals have not been studied with [11 C](+)PHNO. We assessed D2/3 R availability in striatal and extrastriatal reward regions in 14 OB and 14 age- and gender-matched NW individuals with [11 C](+)PHNO PET utilizing a high-resolution research tomograph. Additionally, in regions where group D2/3 R differences were observed, secondary analyses of 42 individuals that constituted an overweight cohort was done to study the linear association between BMI and D2/3 R availability in those respective regions. A group-by-brain region interaction effect (F7, 182 =2.08, p=0.047) was observed. Post hoc analyses revealed that OB individuals exhibited higher tracer binding in D3 -rich regions: the substantia nigra/ventral tegmental area (SN/VTA) (+20%; p=0.02), ventral striatum (VST) (+14%; p<0.01), and pallidum (+11%; p=0.02). BMI was also positively associated with D2/3 R availability in the SN/VTA (r=0.34, p=0.03), VST (r=0.36, p=0.02), and pallidum (r=0.30, p=0.05) across all subjects. These data suggest that individuals who are obese have higher D2/3 R availability in brain reward regions densely populated with D3 Rs, potentially identifying a novel pharmacologic target for the treatment of obesity.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app